Robert J Mentz Selected Research

Cardiovascular Diseases (Cardiovascular Disease)

1/2023	Sex differences in the complications, care and clinical outcomes of patients with type 2 diabetes in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL).
1/2023	Vitamin D Levels in Black Americans and the Association With Left Ventricular Remodeling and Incident Heart Failure With Preserved Ejectin Fraction: The Jackson Heart Study.
1/2023	Longitudinal Changes in Cardiac Troponin and Risk of Heart Failure Among Black Adults.
1/2022	Effect of race on cardiometabolic responses to once-weekly exenatide: insights from the Exenatide Study of Cardiovascular Event Lowering (EXSCEL).
1/2022	Cardiovascular risk stratification in the noncardiac solid organ transplant candidate.
1/2021	Differences between patients with cardiovascular disease and cancer referred for palliative care.
1/2020	Exploring the Possible Impact of Unbalanced Open-Label Drop-In of Glucose-Lowering Medications on EXSCEL Outcomes.
1/2020	Cost-effectiveness of Contemporary Statin Use Guidelines With or Without Coronary Artery Calcium Assessment in African American Individuals.
1/2020	Confirming the Bidirectional Nature of the Association Between Severe Hypoglycemic and Cardiovascular Events in Type 2 Diabetes: Insights From EXSCEL.
12/2019	Incorporation of Biomarkers Into Risk Assessment for Allocation of Antihypertensive Medication According to the 2017 ACC/AHA High Blood Pressure Guideline: A Pooled Cohort Analysis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert J Mentz Research Topics

Disease

240	Heart Failure 05/2024 - 01/2011
23	Type 2 Diabetes Mellitus (MODY) 04/2024 - 04/2016
20	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 01/2014
15	Cardiomyopathies (Cardiomyopathy) 05/2024 - 08/2014
14	Myocardial Infarction 06/2021 - 11/2012
12	Stroke (Strokes) 05/2024 - 01/2014
10	Iron Deficiencies 05/2024 - 04/2019
10	Diabetes Mellitus 01/2020 - 02/2013
9	Dyspnea (Shortness of Breath) 01/2020 - 01/2015
8	Chronic Renal Insufficiency 11/2023 - 12/2012
6	Hypertension (High Blood Pressure) 12/2023 - 12/2012
6	Frailty 11/2023 - 01/2018
5	Atrial Fibrillation 12/2023 - 08/2015
5	Chronic Disease (Chronic Diseases) 12/2023 - 11/2014
5	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 01/2014
5	Chronic Obstructive Pulmonary Disease (COPD) 01/2020 - 04/2012
4	Inflammation (Inflammations) 05/2024 - 10/2016
4	Infections 04/2024 - 01/2020
4	Disease Progression 01/2023 - 03/2017
4	Renal Insufficiency (Renal Failure) 01/2020 - 02/2013
4	Death (Near-Death Experience) 04/2019 - 07/2010
4	Cardio-Renal Syndrome 07/2016 - 07/2010
3	Hypotension (Low Blood Pressure) 03/2024 - 01/2023
3	Peripheral Arterial Disease 10/2021 - 12/2019
3	Weight Loss (Weight Reduction) 01/2021 - 03/2017
3	Edema (Dropsy) 01/2020 - 07/2015
2	Obesity 12/2022 - 01/2020
2	Hyperkalemia 11/2022 - 01/2021
2	Brain Death (Brain Dead) 01/2022 - 01/2020
2	Fibrosis (Cirrhosis) 01/2022 - 03/2015
2	Heart Diseases (Heart Disease) 01/2022 - 12/2015
2	Coronary Disease (Coronary Heart Disease) 01/2022 - 01/2017

Drug/Important Bio-Agent (IBA)

31	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2023 - 03/2015
21	DiureticsIBA 05/2024 - 06/2012
17	Torsemide (Demadex)FDA LinkGeneric 05/2024 - 03/2015
16	Furosemide (Lasix)FDA LinkGeneric 05/2024 - 03/2015
16	sacubitril and valsartan sodium hydrate drug combinationIBA 03/2024 - 01/2017
16	Tolvaptan FDA Link 01/2018 - 11/2012
14	Biomarkers (Surrogate Marker)IBA 05/2024 - 10/2014
14	Vasopressins (Vasopressin)IBA 01/2018 - 11/2012
13	Natriuretic PeptidesIBA 05/2024 - 01/2011
13	Exenatide (Byetta)FDA Link 05/2023 - 04/2016
12	pro-brain natriuretic peptide (1-76)IBA 03/2024 - 01/2018
11	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 05/2024 - 06/2012
10	vericiguatIBA 03/2024 - 01/2021
10	CreatinineIBA 12/2023 - 05/2014
9	SodiumIBA 04/2024 - 02/2013
9	omega-Chloroacetophenone (Mace)IBA 01/2023 - 01/2014
8	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 10/2019
8	AlbuminsIBA 11/2023 - 02/2013
8	Mineralocorticoid Receptor AntagonistsIBA 10/2023 - 07/2012
7	IronIBA 05/2024 - 04/2019
7	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2023 - 07/2012
7	Neprilysin (Neutral Endopeptidase)IBA 11/2022 - 09/2015
7	Angiotensin Receptors (Angiotensin II Receptor)IBA 11/2022 - 09/2015
6	ferric carboxymaltoseIBA 01/2024 - 01/2021
6	TroponinIBA 01/2023 - 12/2015
5	Hemoglobins (Hemoglobin)IBA 01/2022 - 05/2014
5	Uric Acid (Urate)IBA 06/2021 - 12/2014
4	Sodium-Glucose Transporter 2 InhibitorsIBA 04/2024 - 10/2019
4	Valsartan (Vals)FDA Link 03/2024 - 01/2023
4	empagliflozinIBA 10/2023 - 01/2021
4	Troponin IIBA 01/2023 - 12/2018
4	Angiotensin Receptor AntagonistsIBA 11/2022 - 01/2018
4	Spironolactone (Aldactone)FDA LinkGeneric 11/2022 - 01/2017
4	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2021 - 12/2018
3	Proteins (Proteins, Gene)FDA Link 05/2024 - 01/2022
3	paragonIBA 03/2024 - 01/2023
3	PotassiumIBA 11/2022 - 01/2019
3	Sodium-Glucose Transport ProteinsIBA 01/2022 - 01/2021
3	Liraglutide FDA Link 01/2021 - 12/2018
3	Glucagon-Like Peptide-1 Receptor AgonistsIBA 12/2020 - 01/2018
3	Hypoglycemic Agents (Hypoglycemics)IBA 01/2020 - 09/2018
3	AldosteroneIBA 01/2020 - 03/2015
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 01/2016
3	CalciumIBA 01/2020 - 10/2013
3	Glucagon-Like Peptide-1 ReceptorIBA 12/2019 - 04/2016
2	Prealbumin (Transthyretin)IBA 05/2024 - 01/2022
2	Transferrin (beta 2 Transferrin)IBA 05/2024 - 05/2024
2	Indicators and Reagents (Reagents)IBA 05/2024 - 01/2018
2	Enalapril FDA LinkGeneric 03/2024 - 12/2020
2	Urea (Carbamide)FDA LinkGeneric 12/2023 - 09/2015
2	NitrogenIBA 12/2023 - 09/2015
2	Soluble Guanylyl CyclaseIBA 01/2023 - 11/2022
2	dapagliflozinIBA 01/2022 - 10/2019
2	BilirubinIBA 06/2021 - 05/2021

Therapy/Procedure

89	Therapeutics 03/2024 - 01/2011
18	Palliative Care (Palliative Therapy) 11/2023 - 07/2010
11	Patient Readmission 10/2023 - 02/2013
8	Heart-Assist Devices 01/2023 - 05/2013
4	Heart Transplantation (Grafting, Heart) 01/2022 - 01/2020
4	Length of Stay 10/2016 - 04/2012
3	Drug Therapy (Chemotherapy) 12/2022 - 09/2015
3	Secondary Prevention 01/2022 - 01/2017
3	Investigational Therapies (Experimental Therapy) 01/2020 - 07/2010
3	Cardiac Resynchronization Therapy 02/2019 - 02/2015
2	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 07/2023 - 10/2015
2	Hospice Care (Care, Bereavement) 01/2023 - 01/2019
2	Transplantation 01/2022 - 01/2022
2	Surgical Amputation (Amputations) 10/2021 - 12/2019